Both Saint Thomas hospitals face loss of Medicare funding after drug mix-up
NASHVILLE, Tenn. (WTVF) — It’s a stunning new development following that catastrophic medication mix-up last month at Ascension…
Courts reject Medicare price negotiation lawsuits from Merck, AZ
Courts in Maryland and Washington, D.C., have rejected lawsuits by two pharma giants against the Centers for Medicare…
Medicare’s Drug-Pricing Proposal Carries A Hidden Cost
“CMS’s proposal would encourage one thing above all else: investing less in improving existing medicines,” says health expert…
ATLAS breaks its own record with new search for double-Higgs production
Producing two Higgs bosons in a single proton-proton collision is among the rarest processes at the LHC. Yet…
Medicare eliminates key pathways used by ‘breakthrough’ devices for extra payments
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Trump Administration Ends Program that Kept Medicare Premiums Down
The Trump administration is ending a Medicare premium subsidy demonstration program that was intended to stabilize the market…
A Medicare Drug Subsidy Is Ending—Here’s What Patients Should Know
CMS Administrator Mehmet Oz, who called the expiring Part D premium subsidy a “bailout” for insurers, says most…
Rare disease drugmakers seek exclusion from Medicare pricing plans
WASHINGTON — Biotech companies are lobbying the Trump administration to exclude treatments for rare diseases from programs that…
ATLAS hunts for a new “soft” signature of the dark sector
The ATLAS Collaboration releases its first dedicated search for soft unclustered energy patterns (SUEPs) – an elusive possible…
ATLAS tackles a new double-Higgs frontier
The ATLAS Experiment is on the hunt for “ttHH production” – an extremely rare process where two top…
A new trio: ATLAS finds first evidence of ZZy production
The ATLAS Collaboration reports the first evidence of the simultaneous production of a photon and two neutral Z…
Medicare spending far less than expected on new Alzheimer’s drugs
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…